Guide 02 of 03
Cover
Understanding Addiction
Guide 02 of 03

What Does Your Drug Test Tell Your Provider?

A positive or negative result is a data point, not a verdict. This guide explains how urine drug tests actually work, what the results mean, and what questions to ask your provider.

2
Types of test: immunoassay screen and LC-MS/MS confirmation
Varies
Detection window depends on drug, dose, and your own biology
Context
One result alone rarely tells the full clinical story
Section 1 of 5
How the Test Works

Most drug tests use two different methods, and they serve different purposes.

The immunoassay screen is fast and inexpensive, but it detects drug classes broadly and can be fooled by look-alike molecules. LC-MS/MS confirmation identifies specific compounds with high precision.

Test Type How It Works What It Tells You
Immunoassay (IA) Screen Antibodies react when a target molecule is present; result is positive or negative Detects a drug class (e.g., opiates) above a cutoff; does not identify specific compounds
LC-MS/MS Confirmation Separates compounds by molecular weight; identifies and measures specific substances Confirms which exact drug or metabolite is present and at what concentration
Point-of-Care (POC) Rapid lateral-flow strips, similar to immunoassay; results in minutes Preliminary screen only; any positive or unexpected result should be confirmed by lab
Why this matters

A positive on an immunoassay screen means "something was detected." It does not mean the person used that drug. Confirmation by LC-MS/MS is the standard before any significant consequence is applied.

Section 2 of 5
Reading Your Result

Positive and negative results require clinical context to interpret correctly.

A positive result means something was detected above the laboratory's cutoff concentration. A negative result means nothing was detected above that cutoff. Neither tells the complete story without context.

Results are compared against a cutoff concentration, expressed in nanograms per milliliter (ng/mL). A sample that tests below the cutoff reports as negative, even if trace amounts of a substance are present. A sample that exceeds the cutoff reports as positive.

This matters for several reasons. People metabolize drugs at different rates based on body composition, kidney function, hydration, genetics, and other factors. The same amount of a substance can produce very different urine concentrations in different people.

"A drug test tells your provider what was in your urine at that moment. It does not tell them when you used, how much you used, or whether you are impaired."

William Bundy Jr., PharmD | ToxiPharm LLC

Providers trained in clinical toxicology interpret results in the context of your medications, health history, the specific assay used, and the clinical picture. A single result alone is rarely the full story.

Section 3 of 5
False Positives & False Negatives

Drug tests can return unexpected results that do not reflect actual drug use.

False positives and false negatives are documented, clinically recognized phenomena. They are not accusations. They are reasons why confirmation testing and clinical review exist.

False Positive

Test says positive. No drug was used.

Certain medications, supplements, and foods can cross-react with the immunoassay antibody and trigger a positive result. Common examples include ibuprofen (amphetamines), dextromethorphan (PCP), and some antihistamines (opiates). Confirmation testing resolves these.

False Negative

Test says negative. A drug was used.

Some substances fall below the detection cutoff due to timing, dilution, or the specific assay. New synthetic drugs are often not detected by standard panels. Fentanyl, for example, requires its own dedicated test and will not appear on a standard opiate screen.

If you believe a result is incorrect, ask your provider or program about the specific assay used, whether LC-MS/MS confirmation was performed, and what the documented cross-reactants are for that test. These are reasonable clinical questions.

ToxiPharm Tool

The FP/FN Checker lets you look up cross-reactants and documented false positive sources for any drug panel.

Open the FP / FN Checker →
Section 4 of 5
Detection Windows

How long a drug stays detectable depends on many factors, not just when it was used.

Detection windows vary widely by drug, dose, frequency of use, the specific cutoff used by the lab, and the individual's metabolism. These are ranges, not precise timelines.

Drug / Analyte Typical Urine Window Notes
Amphetamines 1 to 3 days Shorter in acidic urine; longer in alkaline urine
Cocaine / Benzoylecgonine 2 to 4 days Heavy use may extend to 1 week
Fentanyl / Norfentanyl 1 to 4 days Requires a dedicated fentanyl assay; not detected by standard opiate screen
THC-COOH (cannabis) 3 days to 4 weeks Highly variable; chronic heavy use may extend well beyond 30 days
Buprenorphine 3 to 7 days Requires dedicated buprenorphine immunoassay or LC-MS/MS
Opiates (morphine/codeine) 2 to 4 days Poppy seed ingestion can produce low-level positive results
Benzodiazepines 3 days to 6 weeks Highly variable; long-acting agents (e.g., diazepam) extend detection significantly
ToxiPharm Tool

The Detection Window Checker provides cutoff-specific detection ranges for every panel drug.

Open the Detection Window Checker →
Section 5 of 5
Talking to Your Provider

You have the right to understand and question your drug test results.

If a result surprises you or does not match your circumstances, these are reasonable questions to ask. Informed patients get better care.

"What assay was used?"

Different platforms have different cross-reactants and cutoffs. Knowing the assay is the starting point.

"Was this confirmed?"

Ask whether LC-MS/MS confirmation was run. A screen alone should not drive major consequences.

"Could my medications cause this?"

List everything you take, including over-the-counter medications and supplements, and ask specifically about cross-reactivity.

If you are in a monitored program

Document the conversation. If a result is disputed, ask for the Medical Review Officer (MRO) process or equivalent clinical review. You should have access to clinical oversight, not just a numerical result and a consequence.


Continue in this series

SAMHSA National Helpline

Free, confidential treatment referrals. Available 24/7, 365 days a year. English and Spanish.

1-800-662-4357

Guide 01: What Is Addiction?

The biology of addiction, the cycle of dependence, and why treatment works.

Read Guide 01 →

Guide 03: Medication-Assisted Treatment

Buprenorphine, methadone, and naltrexone explained: how each works and how they appear on a drug test.

Read Guide 03 →

Clinical Reference

Recommended Reading

For a comprehensive patient-facing overview of opioid use disorder and its treatment, see the ASAM Opioid Use Disorder Patient Guide 2025, published by the American Society of Addiction Medicine and Guideline Central.

This guide is for general educational purposes only and does not constitute medical advice. If you are experiencing a medical emergency, call 911. For substance use support, contact SAMHSA at 1-800-662-4357.

Stay Ahead of What's in the Supply

New Patient Alerts and clinical updates are announced in ToxSignal, the free clinical toxicology newsletter from ToxiPharm.

Educational content is for general informational purposes only and does not constitute medical advice. Consult a qualified healthcare provider for guidance specific to your situation.